Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gibbs

Showing results (361-370 of 393) with videos related to

Pageof 40
Sort By:
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
Blood|April 30, 2011
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityRoberto F Machado, Robyn J Barst, Nancy A Yovetich, et al.
Circulation|September 9, 2011
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United KingdomVandana Sachdev, Gregory J Kato, J Simon R Gibbs, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
The Lancet. Respiratory Medicine|March 27, 2021
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trialMarius M Hoeper, Hikmet Al-Hiti, Raymond L Benza, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease riskS Behera, J R Belyeu, X Chen, et al.
Acta Neuropathologica|July 1, 2020
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson diseaseS Bandres-Ciga, S Saez-Atienzar, J J Kim, et al.
Neurobiology of Aging|March 17, 2018
Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3Celeste Sassi, Michael A Nalls, Perry G Ridge, et al.
Pageof 40

Showing results (361-370 of 393) with videos related to

Sort By:
Pageof 40
The New England Journal of Medicine|April 1, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathMarc Humbert, Vallerie V McLaughlin, David B Badesch, et al.
Blood|April 30, 2011
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityRoberto F Machado, Robyn J Barst, Nancy A Yovetich, et al.
Circulation|September 9, 2011
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United KingdomVandana Sachdev, Gregory J Kato, J Simon R Gibbs, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
The Lancet. Respiratory Medicine|March 27, 2021
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trialMarius M Hoeper, Hikmet Al-Hiti, Raymond L Benza, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease riskS Behera, J R Belyeu, X Chen, et al.
Acta Neuropathologica|July 1, 2020
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson diseaseS Bandres-Ciga, S Saez-Atienzar, J J Kim, et al.
Neurobiology of Aging|March 17, 2018
Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3Celeste Sassi, Michael A Nalls, Perry G Ridge, et al.
Pageof 40